Status: Not yet recruiting
Bioequivalence Study of AG2202
The objective of this study is to evaluate the human bioequivalence of AG2202T and AG2202R.
Participants needed: 34
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: Ahn-Gook Pharmaceuticals Co.,LtdUpdated: Aug 14, 2024
Eligibility criteria
Subjects aged 19 years or older at the time of screening [+3]
Subjects who have taken drugs that induce or inhibit drug metabolizing enzymes w... [+2]